Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinker

Current Opinion in Oncology

Volumn 9, Issue 3, 1997, Pages 257-261

  Koch, Wayne M ^a   McQuone, Shelly ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARCINOGEN; MICROSATELLITE DNA; PROTEIN P53;

AGE; CANCER GENETICS; CANCER RISK; CARCINOGENESIS; CLINICAL FEATURE; CYTOGENETICS; DRINKING; FAMILY HISTORY; GENDER; GENE MUTATION; GENETIC RISK; HEAD AND NECK CARCINOMA; HUMAN; MUTATION RATE; PRIORITY JOURNAL; SHORT SURVEY; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO; TUMOR GROWTH; VIRUS INFECTION; WART VIRUS;

EID: 0030873048     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199709030-00007     Document Type: Short Survey

References (17)

1. Nawroz H, van der Riet P. Hruban R, Koch W. Sidransky D: Allelotype of head and neck squamous carcinoma. Cancer Res 1994, 54:1152-1155.
2. Califano J, van der Riet P, Clayman G. Westra W, Corio R, Koch W, Sidranksky D: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56:2488-2492. A study of 83 preinvasive mucosal lesions analyzing LOH at 10 microsatellite loci. By comparing the frequency of losses in these lesions with that seen in invasive HNSCC, a tumor-progression model is derived. The model places alterations that occur with greater relative frequency in invasive lesions later in the tumorigenesis pathway than those that are already seen with high frequency in the preinvasive lesions.
3. Waber PG, Lee NK, Nisen PD: Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer. Oncogene 1996, 12:365-369.
4. Partridge M, Emilion G. Langdon JD: LOH at 3p correlates with a poor survival in oral squamous cell carcinoma. Br J Cancer 1996, 73:366-371. This study of 3p LOH includes nearly equal numbers of smokers and nonsmokers. offering a rare opportunity to compare the frequency of a molecular alteration in subsets of nearly equal size. Unfortunately, the total number of subjects is too small to achieve statistically significant results. Still, the results suggest that a difference may be demonstrable if a larger cohort can be assembled.
5. Field JK, Kiaris H, Risk JM, Tsiriyotis C. Adamson R, Zoumpourlis V, Rowley H, Taylor K, Whittaker J, Howard P, et al.: Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br J Cancer 1995, 72:1180-1188.
6. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby Y, Couch M, Forastiere AA, Sidransky D: Association between smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med 1995, 332:712-717. The frequency and spectrum of mutation of the p53 gene were determined by direct gene sequencing in 129 HNSCC patients including 24 nonsmokers and nondrinkers. The rate of mutation was significantly lower in the group lacking carcinogen exposure. Smokers had a much broader spectrum of mutations involving many sites, whereas mutations in tumors of nonsmokers were limited to cytosine phosphate guanine sites. This finding provides strong evidence for molecular correlates of carcinogen activity in tumorigenesis of HNSCC.
7. Munirajan AK, Tutsumi-Ishi Y. Mohanprasad BKC, Hirano Y, Munakata N, Shanmugam G, Tsuchida N: p53 gene mutations in oral carcinomas from India. Int J Cancer 1996, 66:297-300.
8. Thomas S, Brennen J, Martel G, Frazer L. Montesano R, Sidransky D, Hollstein M: Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Res 1994, 54:3588-3593.
9. Yokoyama A, Muramatsu T, Ohmori T. et al.: Multiple primary esophageal and concurrent upper aerodigestive tract cancer and the aldehyde dehydrogenase-2 genotype of Japanese alcoholics. Cancer 1996, 77:1986-1990
10. Muscat JE, Richie JP, Thompson S, Wynder EL: Gender differences in smoking and risk for oral cancer. Cancer Res 1996, 56:5192-5197. The authors of this large. case-controlled study consider the contribution of gender and tobacco use to HNSCC. In all smoking categories, the risk for women was much greater than that for men.
11. Cloos J, Spitz MR, Schantz SP, Hsu TC, Zhang Z, Tobi H, Braakhuis BJM, Snow GB Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 1996, 88:530-535 The combination of chromosome fragmentability and tobacco exposure produces the highest odds ratio for HNSCC (odds ratio = 44.6), evidence that an inherited susceptibility to the effect of carcinogens plays a role in tumorigenesis.
12. Ishwad CS, Ferrel RE, Rossie KM, Appel BN, Johnson JT, Myers EN, Law JC, Srivastava S, Gollin SM: Microsatellite instability in oral cancer. Int J Cancer 1995, 64:332-335.
13. Koch WM, Patel H, Brennan JA, Boyle JO, Sidransky D: Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg 1995, 121:262-265.
14. Ankathil R, Mathew A, Joseph F, Nair MK: Is oral cancer susceptibility inherited?: report of five oral cancer families. Oral Oncol, Eur J Cancer 1996, 32B:63-67.
15. Foulkes WD, Brunet JS, Kowalski LP, Narod SA, Franco EL: Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case control study. Int J Cancer 1995, 63:769-773.
16. Shindoh M, Chiba I, Yasuda M, Saito T, Funaoka K, Kohgo T, Amemiya A, Sawada Y, Fujinaga K: Detection of human papillomavirus in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression. Cancer 1995, 76:1513-1521.
17. Snijders PJ, Scholes AG, Hart CA, Jones AS, Vaughan ED, Woolgar JA, Meijer CJ, Walboomers JM, Field JK: Prevalence of mucosotropic human papillomaviruses in squamous cell carcinoma of the head and neck. Int J Cancer 1996, 66:464-469.